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ABSTRACT: PURPOSE  Exercise therapy in patients 
with metabolic  chronic disease  produces   several 
positive response. This study aims  to verify  the effects  
of fast  walking associated to a resistance exercise to 
reduce cardiovascular risk factor. METHODS:  Two  
groups  of  subjects (10 cancer  survivors and 19 
hypertensive patients) were   evaluated  by  6-Minute 
Walking Test (6MWT), bioimpedance, ,  the Sit & 
Reach Test (S&R) evaluate  the flexibility, Handgrip 
and 30’’ Chair Test for muscular strength. Patients 
were tested before and after 3 months of regular 
physical exercise. RESULTS: A significant  change in 
anthropometric parameters  was observed (BMI: T0 =  
29.2±6.8, T3= 27.4±4.4 kg/m2  p<.001; waist 
circumference: T0=92.5±14.1, T3=92.1±12.8 cm, 
p<.05) in the  hypertensive  population.  A  
predominant  improvement  of  the  cardiovascular 
parameters was observed in the cancer survivors (rest 
DBP T0=76.4±6.5, T3=72.2±7.1 mmhg p<.05; 6MWT: 
T0=487.8±116.0, T3= 525.6±117.3 m  p<.05; S&R: 
T0= 0.4±7.4, T3=4.1±6.1 cm p<.05). CONCLUSION: 
A combined aerobic and resistance exercise 
programme can  improve cardiovascular  risk factors in 
hypertensive  subjects. The same  programme induces 
improvement in exercise  tolerance and  flexibility  
variables in cancer survivors.  
 
INTRODUCTION: Marked technological and 
pharmacological advances in the management of 
cardiovascular disease and its associated risk factors 
have been made [1]. The positive effects of exercise as 
a prescription therapy, especially fast walking 
programme, in patients with chronic metabolic disease 
have been recently demonstrated  [2]. Hypertension 
remains a major public health problem [3]. Cancer is 
the second  cause of death, and is superimposed to 
metabolic conditions including obesity or overweight. 
Non supervised exercise programmes have been 
proposed in both cancer and hypertensive patients  [4]. 
Many clinical trials in this field are limited to  a few 
weeks, and do not investigate the effects of the 
combination of the aerobic and resistance  exercise. In 
addition, the global response and the possible 
differences between these two conditions after a short 
period of training  have not been investigated. The 
present study aims to verify the possible impact of a 
non supervised aerobic exercise programme associated 
to resistance exercise on several anthropometric and 
haemodynamic variables in cancer and hypertensive 
patients.  
METHODS: Two groups of subjects (one composed 
of 5 female breast and 5 male colon overweight cancer 
survivors, aged 48.8 ±4.6, in good clinical conditions, 
previously treated with chemotherapy,  without   
evidence of  cardiovascular disease;  the  other of  19 
subjects, aged 54.3± 3.7 affected by  mild hypertension  
under pharmacological management) took part in the 
present study. They were prescribed an exercise 
programme composed of aerobic (fast walking) and 
resistance exercises (home based exercises for the 
upper and lower limb, without weight lifting at the 
beginning of the programme). Lifestyle was evaluated 
by a questionnaire to ascertain their levels of physical 
activity. Following the ACSM guidelines, the intensity 
of aerobic exercise was set at 60% maximal effort  for 
at  least three times a week for at least three months  
The resistance exercises programme included simple 
exercises: home based isotonic exercise for the upper 
and lower limb, without weight lifting at the beginning 
of the program. Initially, we recommended 2 sets of 10 
repetitions per each set to increase according to 
subjective perception, never exceeding 3 sets of 20 
repetitions for each exercise. Flexibility exercises 
involving the calf muscles, quadriceps and hamstring 
consisted of one set of static stretching exercises in 
which the subject maintained the stretch for at least one 
minute.  
The aerobic exercise prescription was based on the 
results of the 6-Minute Walking Test (6MWT): heart 
rate, respiratory rate, systolic and diastolic blood 
pressure (DBP) were assessed at rest and at the end of 
the test [5]. The intensity  of the  aerobic  exercise was  
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obtained by the  formula (HRt = 60%  × (HRmax − 
HRrest) + HRrest,) where HRt is the target heart rate, 
HRmax is maximum heart rate, and HRrest is heart rate 
at rest. Heart  rate values were  evaluated  using a  
dedicated software (Zephyr Bioharness model 
9600.0091, Annapolis, Maryland U.S.A.) for  telemetry 
using an elastic strap placed on the chest. The  heart 
rate corresponding to 60%  of the final value  obtained 
was the target of the intensity of  the  exercise  
corresponding  to  the maximum tolerated effort per 
each subject. Following  the  ACSM  guidelines, the 
duration of the aerobic exercise per session  was 30 
minute for at  least  3 times  a week, up  to a maximum 
of  150 min per week. The duration of the aerobic  
exercise, was established  also from  the  effective 
effort tolerance  derived from the CR10  scale  
evaluation  at  the  end  of  the 6MWT test.  The results 
of the 6MWT were  integrated with the CR10 score to 
determine the final intensity of the aerobic exercise in 
term of heart rate  per minute  [6]  
We measured the distribution of the Intra (ICW) and 
Extracellular (ECW) water by Bioimpedance (BIA) 
analysis [7] The data collected were processed with a 
dedicated software (Bodygram pro 3.0). We measured 
weight, height, Body Mass Index (BMI), Basal 
Metabolism (BM), Phase Angle (PA), Free Fat Mass 
(FFM), Fat Mass (FM), Total Body Water (TBW), 
Extra Cellular Water (ECW), Intra Cellular Water 
(ICW), Body Cellular Mass (BCM).  
For resistance exercise prescription, the muscle 
strength of the upper and lower limbs  and flexibility 
were evaluated by the Sit & Reach Test (S&R), the 
Handgrip, and the 30” Chair Test [8]. All the tests were 
performed at baseline and after 3 month of regular 
physical exercise. 
RESULTS: At baseline, both groups were at the upper 
limits of the overweight range. After 3 months of 
regular and unsupervised mixed exercises, a  
significant reduction of anthropometric variables was 
evident (Tab. 1) Blood Pressure remained unchanged. 
The cardiovascular and resistance exercises variables 
improved significantly in the cancer group, but 
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 Cancer T0 Cancer T3 p value Hypertensive T0 Hypertensive T3 p value 
Age (years) 48.8 ± 4.6   54.3±3.7   
Height (cm) 165.5±12.0 165.5±12.0 NS 163.5±10.0 163.5±10.0 NS 
Weight (kg) 82.2±23.5 80.6±21.6 NS 77.9±16.6 76.2±15.8 <0.00 
BMI (kg/m2) 30.3±10.3 29.8±9.7 NS 29.2±6.8 27.4±4.4 <0.00 
Abdominal (cm) 92.4±19.2 90.9±17.3 NS 92.5±14.1 92.1±12.8 <0.05 
waist (cm) 109.2±21.1 110.5±19.2 NS 101.1±8.6 101.0±8.5 NS 
Abd/Waist 0.8±0.1 0.8±0.1 NS 0.9±0.1 0.9±0.1 NS 
RZ (ohm) 542.7±91.2 569.7±104.1 <0.05 520.5±82.8 513.4±86.0 NS 
XC (ohm) 59.9±10.5 61.4±11.6 NS 58.1±17.6 55.9±12.3 NS 
PA (°) 6.4±1.1 6.2±0.7 NS 6.4±1.4 6.2±1.1 NS 
TBW (Lt) 38.1±8.2 37.0±7.9 <0.04 39.9±8.6 38.1±8.1 NS 
ECW (Lt) 16.9±3.9 16.7±3.8 NS 17.5±3.7 17.2±3.9 <0.05 
ICW (Lt) 21.2±4.9 20.3±4.6 NS 20.9±4.8 21.9±4.2 NS 
BMR (kcal) 1521.1±152.8 1525.0±182.7 NS 1536.4±187.5 1556.1±174.5 NS 
Rest HR (bpm) 77.1±9.2 74.0±12.4 NS 76.3±12.1 71.2±9.9 NS 
HR 6'WT (bpm) 137.4±12.9 131.5±15.2 NS 126.9±18.2 127.9±15.3 NS 
RR 6'WT (bpm) 30.0±6.7 29.0±5.3 NS 42.5±19.6 39.5±9.1 NS 
rest SBP (mmhg) 121.7±8.7 118.3±13.2 NS 128.3±7.5 126.9±12.5 NS 
rest DBP (mmhg) 76.4±6.5 72.2±7.1 <0.05 82.0±7.1 78.1±9.9 NS 
SBP 6'WT (mmhg) 141.7±10.9 135.3±7.1 NS 153.8±8.3 141.8±12.0 NS 
DBP 6'WT (mmhg) 73.7±6.3 70.6±6.8 NS 75.6±8.6 72.5±6.4 NS 
 6'M WT (m) 487.8±116.0 525.6±117.3 <0.05 590.0±67.3 575.4±56.9 NS 
CR10 5.7±3.3 4.9±2.9 NS 3.0±2.1 2.7±2.1 NS 
Sit & Reach (cm) 0.4±7.4 4.1±6.1 <0.05 -5.2±8.3 -6.2±6.5 NS 
Chair Test (rip) 11.8±2.2 14.1±3.9 NS 16.6±3.4 16.4±2.8 NS 
Hand Grip right (kg) 29.3±17.2 27.5±5.1 NS 36.3±10.2 33.8±11.6 NS 
Hand Grip left (kg) 30.5±13.4 27.2±5.6 NS 34.0±9.1 33.2±11.9 NS 
Table 1: results of 3 months of exercise in all parameters evaluated 
Legend: 
BMI (Body Mass Index); Abd/Waist (Abdominal/waist); RZ (Resistance);  XC(Reactance); PA (Phase Angle); TBW 
(Total Body Water); ECW (Extra Cellular Water); ICW (Intra Cellular  Water); BMR (Body Metabolic Rate); 
HR(Heart Rate); HR6’WT(Heart Rate 6 minute  Walking Test); RR 6’WT (Respiratory Rate 6 minute Walking Test); 
SBP(Systolic Blood Pressure); DBP (Diastolic Blood  Pressure); CR10(Category-Ratio scale of Effort),   
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DISCUSSION 
The  number of cancer survivors is now growing. In 
parallel, the amount of aged subjects with increased 
cardiovascular risk is increasing (11,12). The presence 
of metabolic syndrome in cancer represents often the 
main reason to introduce new treatment strategies. The 
onset of metabolic syndrome in cancer survivors may 
cause the long term morbidities the complications of 
which can interfere with cancer treatment and worsen  
the quality of  life. Regular physical exercise has 
antinflammatory effects, which may benefit cancer 
patients (13). The adipose tissue is the primary site of 
production of inflammatory factors, as IL6, TNF, and it 
can be responsible, in the tumorgenesis process, for the 
activation of distant metastases(14).Aerobic  [9] and 
resistance exercise [10] can each produce  significant 
positive effects on body fitness, muscle function and 
body composition, both in hypertensive patients and  in 
cancer survivors. The combination of aerobic and 
resistance exercise can reduce the metabolic risk 
factors in cancer survivors and in hypertensive patients.  
The present study has shown that in cancer survivors a 
short period of mixed aerobic and resistance exercises, 
a predominant  improvement in aerobic exercise 
tolerance and flexibility. This is not the case in 
hypertensive patients, in whom it is possible that the 
duration and intensity of the exercise programme used 
in the present study is not sufficient to elicit the desired 
effect.  
 These results support the short term efficacy of non 
supervised  and combined aerobic and resistance 
exercise programme.  The effects of such exercise 
programme are different in these two groups of 
patients, and will need  further investigations with 
larger cohorts and longer follow up. Nevertheless, the 
results are promising, and may result in a greater rate 
of exercise prescription in these patients, with 
reduction of cardiovascular risk factors and 
improvement in quality of life.  
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